Symetrify

Company Overview

Snapshot

Founded in February 2022 by Asher Castiel and Ami Eyal, Symetrify operates with 1–10 employees. The company has secured funding across one round from two investors, with eHealth Ventures participating. Symetrify is developing the L-PACT, a neuromechanical wearable training device for chronic low back pain.

Business overview

Symetrify develops the L-PACT, a neuromechanical wearable training device designed for assessing, treating, and preventing spinal kinetic dysfunctions associated with chronic low back pain (CLBP). The L-PACT addresses the functional-mechanical root cause of CLBP by balancing lumbo-pelvic load distribution, offering an automated training solution to halt degenerative processes. This technology utilizes data-driven AI algorithms to provide predictive markers for motion imbalances, delivering personalized therapeutic effects for patients and enhancing treatment efficiency for clinicians. The company operates in the Health Tech & Life Sciences sector, specifically within Medical Devices, Digital Healthcare, and Digital Therapeutics, serving healthcare providers in markets such as the United States.

Company Intelligence Q&A

When was Symetrify founded and by whom?

Symetrify was founded in February 2022 by co-founders Asher Castiel and Ami Eyal.

What is Symetrify's core product?

Symetrify's core product is the L-PACT, a neuromechanical wearable training device designed for the assessment, treatment, and prevention of spinal kinetic dysfunctions related to chronic low back pain.

What technology does the L-PACT device utilize?

The L-PACT device utilizes data-driven AI algorithms to provide predictive markers for developing low back motion imbalances and offers personalized therapeutic effects.

Which markets does Symetrify target?

Symetrify targets geomarkets including the United States with its L-PACT device.

What is the primary business model of Symetrify?

Symetrify operates with a B2B business model.